S&P 500
7,372.40
-0.17%
Dow Jones
50,821.90
0.00%
Nasdaq 100
28,981.30
-0.47%
Russell 2000
2,858.99
-0.25%
FTSE 100
10,275.50
-0.22%
Nikkei 225
64,738.70
+0.49%

Investing

COLL logo Collegium Pharmaceutical : COLL

COLL

Stock Data

$34.40

Change up

$1.13 (3.40%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

DRUG MANUFACTURERS - SPECIALTY & GENERIC

Collegium Pharmaceutical Inc specializes in creating innovative pain management medications. Their product lineup features Xtampza ER, a unique formulation designed to deter abuse while providing extended pain relief, and Nucynta, available in both extended and immediate-release versions for various pain intensities. They also offer Belbuca, a buprenorphine-based film for pain management, and Symproic, aimed at treating opioid-induced constipation in adults. Founded in 2002 and based in Stoughton, Massachusetts, Collegium is dedicated to improving the lives of people dealing with chronic pain.

All Collegium Pharmaceutical Articles

1 Article